| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 12, 2005
Accepted on October 20, 2005
Through Neutral Sphingomyelinase 2, Sphingosine Kinase 1, and Sphingosine 1 Phosphate Receptors. A Novel Pathway Relevant to the Pathophysiology of Endothelium
From the Department of Pharmaco-Biology (C.D.P., C.P.), University of Calabria, Rende; Stem Cell Research Institute (C.D.P., C.P., E.C.), DIBIT-H San Raffaele Institute, Milan; the Department of Biochemical Sciences (E.M., P.B.), University of Firenze; E. Medea Scientific Institute (E.C.), Bosisio Parini; and the Department of Preclinical Sciences (E.C.), University of Milan, Italy.
* To whom correspondence should be addressed. E-mail: clementi.emilio{at}hsr.it.
Objective--Tumor necrosis factor (TNF)
, a key proinflammatory cytokine acting on the endothelium, activates endothelial nitric oxide synthase (eNOS). We have examined the signaling pathway leading to this activation and its biological role in endothelium, which are still unknown.
Methods and Results--In human endothelial cells, we found that eNOS activation by TNF-
is time dependent and requires activation of Akt, a known eNOS activator. eNOS activation was preceded by sequential activation of neutral-sphingomyelinase-2 (N-SMase2) and sphingosine-kinase-1 (SK1) and generation of sphingosine-1-phosphate (Sph1P). Inhibition of N-SMase2 inhibited Sph1P formation, whereas inhibition of SK1 did not affect N-SMase2 activation by TNF-
. Blockade of N-SMase2, SK1, or the Sph1P receptors S1P1 and S1P3, either by silencing or pharmacological inhibitors, prevented eNOS activation. Thus, eNOS is activated by TNF-
via S1P receptors, activated by Sph1P generated through N-SMase2 and SK1 activation. We found that nitric oxide generated through this pathway has a biological role, because it inhibits the expression of E-selectin and the adhesion of dendritic cells to the endothelium stimulated by TNF-
.
Conclusions--This study establishes a previously undescribed link among TNF-
, Sph1P, and eNOS in a same signaling pathway of biological relevance in the process of endothelial cell activation by TNF-
.
neutral sphingomyelinase 2
sphingosine kinase 1
sphingosine 1 phosphate
This article has been cited by other articles:
![]() |
A. Montfort, B. de Badts, V. Douin-Echinard, P. G. P. Martin, J. Iacovoni, C. Nevoit, N. Therville, V. Garcia, M.-A. Bertrand, M.-H. Bessieres, et al. FAN Stimulates TNF{alpha}-Induced Gene Expression, Leukocyte Recruitment, and Humoral Response J. Immunol., October 15, 2009; 183(8): 5369 - 5378. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ding, N. C. Kirkiles-Smith, and J. S. Pober FOXO3a Regulates Oxygen-responsive Expression of Tumor Necrosis Factor Receptor 2 in Human Dermal Microvascular Endothelial Cells J. Biol. Chem., July 17, 2009; 284(29): 19331 - 19339. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Formigli, C. Sassoli, R. Squecco, F. Bini, M. Martinesi, F. Chellini, G. Luciani, F. Sbrana, S. Zecchi-Orlandini, F. Francini, et al. Regulation of transient receptor potential canonical channel 1 (TRPC1) by sphingosine 1-phosphate in C2C12 myoblasts and its relevance for a role of mechanotransduction in skeletal muscle differentiation J. Cell Sci., May 1, 2009; 122(9): 1322 - 1333. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sattler and B. Levkau Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection Cardiovasc Res, May 1, 2009; 82(2): 201 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Snider, T. Kawamori, S. G. Bradshaw, K. A. Orr, G. S. Gilkeson, Y. A. Hannun, and L. M. Obeid A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis FASEB J, January 1, 2009; 23(1): 143 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Clark, S. J. Huang, G. F. Murphy, I. G. Mollet, D. Hijnen, M. Muthukuru, C. F. Schanbacher, V. Edwards, D. M. Miller, J. E. Kim, et al. Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells J. Exp. Med., September 29, 2008; 205(10): 2221 - 2234. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Hudson, M. O'Hara, H. A. Lacey, J. Corcoran, D. G. Hemmings, M. Wareing, P. Baker, and M. J. Taggart Modulation of Human Arterial Tone During Pregnancy: The Effect of the Bioactive Metabolite Sphingosine-1-Phosphate Biol Reprod, July 1, 2007; 77(1): 45 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhao, S. K. Kalari, P. V. Usatyuk, I. Gorshkova, D. He, T. Watkins, D. N. Brindley, C. Sun, R. Bittman, J. G. N. Garcia, et al. Intracellular Generation of Sphingosine 1-Phosphate in Human Lung Endothelial Cells: ROLE OF LIPID PHOSPHATE PHOSPHATASE-1 AND SPHINGOSINE KINASE 1 J. Biol. Chem., May 11, 2007; 282(19): 14165 - 14177. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C.M. Mulders, S. L.M. Peters, and M. C. Michel Sphingomyelin metabolism and endothelial cell function Eur. Heart J., April 1, 2007; 28(7): 777 - 779. [Full Text] [PDF] |
||||
![]() |
M. Tani and Y. A. Hannun Neutral Sphingomyelinase 2 Is Palmitoylated on Multiple Cysteine Residues: ROLE OF PALMITOYLATION IN SUBCELLULAR LOCALIZATION J. Biol. Chem., March 30, 2007; 282(13): 10047 - 10056. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Clarke, T.-G. Truong, and Y. A. Hannun Role for Neutral Sphingomyelinase-2 in Tumor Necrosis Factor {alpha}-Stimulated Expression of Vascular Cell Adhesion Molecule-1 (VCAM) and Intercellular Adhesion Molecule-1 (ICAM) in Lung Epithelial Cells: p38 MAPK IS AN UPSTREAM REGULATOR OF nSMase2 J. Biol. Chem., January 12, 2007; 282(2): 1384 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C.M. Mulders, M. C. Hendriks-Balk, M.-J. Mathy, M. C. Michel, A. E. Alewijnse, and S. L.M. Peters Sphingosine Kinase-Dependent Activation of Endothelial Nitric Oxide Synthase by Angiotensin II Arterioscler Thromb Vasc Biol, September 1, 2006; 26(9): 2043 - 2048. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |